Skip to main content
. 2022 Nov 17;2022(11):CD014963. doi: 10.1002/14651858.CD014963.pub2

Comparison 5. Subgroup analysis: < 70 years versus ≥ 70 years for the comparison of systemic corticosteroids versus standard care (plus/minus placebo) for hospitalised individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
5.1 All‐cause mortality up to 30 days 3 6781 Risk Ratio (M‐H, Random, 95% CI) 0.88 [0.71, 1.10]
5.1.1 < 70 years 3 3885 Risk Ratio (M‐H, Random, 95% CI) 0.70 [0.60, 0.82]
5.1.2 ≥ 70 years 3 2896 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.92, 1.12]